These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 19683313)

  • 1. Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia.
    Parsons JK; Im R
    J Urol; 2009 Oct; 182(4):1463-8. PubMed ID: 19683313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.
    Parsons JK
    J Urol; 2007 Aug; 178(2):395-401. PubMed ID: 17561143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms--what do we know?
    Sarma AV; Parsons JK; McVary K; Wei JT
    J Urol; 2009 Dec; 182(6 Suppl):S32-7. PubMed ID: 19846144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol consumption decreases risk of BPH.
    Rees J
    Practitioner; 2009 Dec; 253(1724):5, 3. PubMed ID: 20120825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions.
    Parsons JK; Sarma AV; McVary K; Wei JT
    J Urol; 2009 Dec; 182(6 Suppl):S27-31. PubMed ID: 19846130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology, epidemiology, and natural history of benign prostatic hyperplasia.
    Bushman W
    Urol Clin North Am; 2009 Nov; 36(4):403-15, v. PubMed ID: 19942041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk of treatment for benign prostatic hyperplasia in Japanese men: a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    Int J Urol; 2013 Jan; 20(1):100-6. PubMed ID: 23106204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
    Kristal AR; Arnold KB; Schenk JM; Neuhouser ML; Weiss N; Goodman P; Antvelink CM; Penson DF; Thompson IM
    J Urol; 2007 Apr; 177(4):1395-400; quiz 1591. PubMed ID: 17382740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance rates and modifiable risk factors for lower urinary tract symptoms in twins.
    Rohrmann S; Fallin MD; Page WF; Reed T; Partin AW; Walsh PC; Platz EA
    Epidemiology; 2006 Jul; 17(4):419-27. PubMed ID: 16699472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of serum dihydrotestosterone and subsequent risk of benign prostatic hyperplasia in community dwelling men: the Rancho Bernardo Study.
    Parsons JK; Palazzi-Churas K; Bergstrom J; Barrett-Connor E
    J Urol; 2010 Sep; 184(3):1040-4. PubMed ID: 20643424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia.
    St Sauver JL; Jacobson DJ; McGree ME; Lieber MM; Jacobsen SJ
    Am J Epidemiol; 2006 Oct; 164(8):760-8. PubMed ID: 16905643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic sequence variants are associated with severity of lower urinary tract symptoms and prostate cancer susceptibility.
    Helfand BT; Hu Q; Loeb S; McVary KT; Catalona WJ
    J Urol; 2013 Mar; 189(3):845-8. PubMed ID: 23159463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case-control study on the risk factors of benign prostatic hyperplasia in the suburb of Shenyang].
    Ning X; Shi JP; Wu ZY; Zheng LG; Wang HL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Apr; 24(4):276-80. PubMed ID: 12820944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions.
    Parsons JK; Sarma AV; McVary K; Wei JT
    J Urol; 2013 Jan; 189(1 Suppl):S102-6. PubMed ID: 23234610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia.
    Nichol MB; Knight TK; Wu J; Barron R; Penson DF
    J Urol; 2009 May; 181(5):2214-21; discussion 2221-2. PubMed ID: 19296986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and treatment of lower urinary tract symptoms in older men.
    Abrams P; Chapple C; Khoury S; Roehrborn C; de la Rosette J;
    J Urol; 2009 Apr; 181(4):1779-87. PubMed ID: 19233402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms.
    Parsons JK; Kashefi C
    Eur Urol; 2008 Jun; 53(6):1228-35. PubMed ID: 18358592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms.
    Parsons JK
    Curr Opin Urol; 2011 Jan; 21(1):1-4. PubMed ID: 21045705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relief by botulinum toxin of lower urinary tract symptoms owing to benign prostatic hyperplasia: early and long-term results.
    Brisinda G; Cadeddu F; Vanella S; Mazzeo P; Marniga G; Maria G
    Urology; 2009 Jan; 73(1):90-4. PubMed ID: 18995889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.